Aclaris Therapeutics, Inc. Gains 31.01%

Fri, Oct 25, 2024 at 07:42 PM

Aclaris Therapeutics, Inc. (ACRS:NASDAQ) shot up at $1.69, a gain of 31%. On Fri, Oct 25, 2024, ACRS:NASDAQ touched a New 2-Week High of $1.69. The stock appeared on our News Catalysts scanner on Wed, Oct 23, 2024 at 08:50 PM in the 'MISCELLANEOUS' category. From Fri, Oct 11, 2024, the stock recorded 70.00% Up Days and 72.73% Green Days

About Aclaris Therapeutics, Inc. (ACRS:NASDAQ)

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

Top 10 Gainers:

Smart for Life Inc. (SMFL:NASDAQ), 172.09%
Upexi Inc Com (UPXI:NASDAQ), 170%
ARB IOT Group Limited (ARBB:NASDAQ), 107.3%
NWTN Inc. (NWTN:NASDAQ), 62.44%
Iterum Therapeutics plc (ITRM:NASDAQ), 60.68%
BM Technologies Inc. (BMTX:NYSEMKT), 47.21%
Fitell Corporation (FTEL:NASDAQ), 44.39%
SRAX, Inc. (SRAX:NASDAQ), 40%
Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 36.86%
Aclaris Therapeutics, Inc. (ACRS:NASDAQ), 31.01%